![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients AMRI extends long term supply deal with GE Healthcare7:41 AM MST | December 7, 2012 | Deepti Ramesh Albany Molecular Research (AMRI; Albany, NY) says its commercial supply deal with GE Healthcare has been extended. AMRI, under the deal, will supply aminobisamide hydrochloride (ABA), an intermediate material used in diagnostic imaging agents. The new contract extends through 31 December 2016, and replaces the existing supply contract between GE and AMRI that has been in effect since 2005. Production will continue at AMRI’s large-scale manufacturing subsidiary located at Rensselaer, NY. “The ABA product relationship with GE Healthcare has been an... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|